BMS-188797

Star0

DB12619InvestigationalSmall molecule

BMS-188797 has been used in trials studying the treatment of Unspecified Adult Solid Tumor, Protocol Specific.

Formula / weight: C₄₇H₅₁NO₁₅ · 869.917 g/mol (avg)
Code names: BMS-188797

Resolves to

Compound

UNII0HG7S0S581CAS172481-83-3ChEMBLCHEMBL1096237PubChem6918494

Structure

InChIKeyGMJWGJSDPOAZTP-MIDYMNAOSA-NSMILES

COC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@]1(C)[C@@H]2[C@H](OC(=O)C2=CC=CC=C2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C3=CC=CC=C3)C3=CC=CC=C3)C(C)=C([C@@H](OC(C)=O)C1=O)C2(C)C

What you can answer from here — as of April 02, 2025

2Clinical trialsPhase, status and sponsor resolved per trial

Which companies are running trials of BMS-188797, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account